Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $119.4 million.

  • Kyntra Bio's Total Non-Current Liabilities fell 7433.16% to $119.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.4 million, marking a year-over-year decrease of 7433.16%. This contributed to the annual value of $397.3 million for FY2024, which is 3183.08% down from last year.
  • According to the latest figures from Q3 2025, Kyntra Bio's Total Non-Current Liabilities is $119.4 million, which was down 7433.16% from $359.0 million recorded in Q2 2025.
  • Over the past 5 years, Kyntra Bio's Total Non-Current Liabilities peaked at $605.1 million during Q4 2022, and registered a low of $119.4 million during Q3 2025.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $518.7 million (2021), whereas its average is $478.7 million.
  • Per our database at Business Quant, Kyntra Bio's Total Non-Current Liabilities soared by 8775.41% in 2021 and then tumbled by 7433.16% in 2025.
  • Quarter analysis of 5 years shows Kyntra Bio's Total Non-Current Liabilities stood at $518.7 million in 2021, then rose by 16.67% to $605.1 million in 2022, then dropped by 3.68% to $582.9 million in 2023, then plummeted by 31.83% to $397.3 million in 2024, then tumbled by 69.94% to $119.4 million in 2025.
  • Its Total Non-Current Liabilities was $119.4 million in Q3 2025, compared to $359.0 million in Q2 2025 and $339.3 million in Q1 2025.